This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07467/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07467/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07467/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07467/identifier/pdb/

Statements

Subject Item
n2:DB07467
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07467 n13:DB07467
dcterms:title
4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide
adms:identifier
n9:12598931 n10:99443938 n11:DB07467 n12:BL1
n3:IUPAC-Name
n4:271B471F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4725-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4724-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4721-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4722-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4723-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B471D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B471B-363D-11E5-9242-09173F13E4C5 n4:271B471E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B471C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B472B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B472C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4726-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4727-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4729-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4728-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B472A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4731-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4733-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4734-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4730-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B472F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4732-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4720-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B472D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B472E-363D-11E5-9242-09173F13E4C5